Read More

Earnings Outlook For VistaGen Therapeutics

VistaGen Therapeutics (NASDAQ:VTGN) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. Analysts estimate that VistaGen Therapeutics will report an earnings per share (EPS) of $-0.07.

VTGN

Read More

Vistagen Announces The Two Leading Proxy Advisory Firms, Institutional Shareholder Services And Glass Lewis, Recommend Stockholders Vote “For” Proposal No. 5 To Provide Its Board With The Option To Implement A Future Reverse Stock Split, If Necessary

Vistagen Therapeutics, Inc. (NASDAQ:VTGN) (the Company), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central

VTGN